Mucus Degradation Index: A Functional Read on Your Gut Barrier

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Measures how strongly your gut microbiome degrades the intestinal mucus barrier, revealing whether your protective mucus layer may be compromised. Identifying excessive mucus degradation can help you reduce risk of gut barrier disruption and related digestive inflammation or infections.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

A functional readout of how hard your microbes eat your mucus

The mucus degradation index test is a stool-based analysis that estimates how strongly your gut microbes are breaking down the intestinal mucus layer (rich in mucin proteins). Many labs calculate the index from metagenomic sequencing, which tallies microbial genes linked to mucin breakdown (glycosidases, sulfatases, sialidases), and some complement this with direct enzyme-activity assays. These approaches go beyond listing which bacteria are present to reveal what they can do. In practical terms, you’re seeing the functional capacity of your microbiome to consume mucus compared with a reference population. Results reflect your current ecosystem and habits rather than a permanent trait.

Why it matters: the gut mucus barrier separates trillions of microbes from your intestinal wall, helping maintain calm cross-talk with your immune system. When microbes rely more on mucus for fuel, that barrier can thin and the gut may become more permeable. That can amplify local inflammation, disturb digestion, and influence metabolic and immune signaling through the gut–brain and gut–liver axes. Microbiome science keeps evolving, though consistent patterns emerge: stable diversity, steady short-chain fatty acid production, and balanced mucin use align with resilient gut function.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

When microbes pivot from fiber to mucus

Your microbes are adaptable. When dietary fiber is plentiful, many prefer fermenting those carbs into short-chain fatty acids that nourish your colon lining. When fiber is scarce, some species pivot to digesting your own mucus. The mucus degradation index helps reveal that shift in action. Elevated mucin-degrading potential, especially alongside low butyrate-producing bacteria (e.g., Faecalibacterium), can align with symptoms like bloating, urgency, or loose stools and with conditions marked by barrier stress. It can also clarify why a stretch of travel food, a hard training block, or an antibiotic course left your gut more reactive. If you’ve tried elimination diets without answers, the index offers a different angle by focusing on the barrier rather than only on triggers.

In the bigger picture, the gut barrier influences whole-body health, from glucose regulation to skin reactivity and mood. Tracking the index over time shows how your routines shape barrier resilience. Think of it like a dashboard light: not a diagnosis, but a meaningful signal that prompts context and collaboration. It is most informative when interpreted with your symptoms, stool form, recent medications, and companion labs (for example, fecal calprotectin for inflammation, secretory IgA for mucosal immune tone, or stool short-chain fatty acids for fermentation balance). Important limitations: the index is a snapshot; antibiotics, colonoscopy prep, acute illness, or laxatives can temporarily skew results. Assays differ across labs, so reference ranges are platform-specific, and more research is needed to define risk thresholds across life stages, including pregnancy.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Reading a low, typical, or high index

Most reports present the mucus degradation index as low, typical, or high relative to a reference population, sometimes alongside the abundance of key mucin-degrading genes and taxa. A “balanced” pattern generally pairs moderate mucin use with healthy representation of butyrate producers and adequate overall diversity. Overrepresentation of mucin-degrading potential, especially with low fiber fermenters, may indicate a microbiome leaning on your mucus for fuel.

Balanced or “optimal” often means efficient digestion, steady short-chain fatty acid output, and a sturdy mucus layer with low inflammatory signaling. Akkermansia muciniphila is a useful example: it can consume mucin yet is associated with metabolic benefits when present in proportion. Context matters, and ranges vary widely by diet, geography, and genetics.

Imbalanced or “dysbiotic” patterns may include high mucinase, sialidase, or sulfatase potential, less microbial diversity, or fewer butyrate producers. That does not equal a disease diagnosis. It highlights a functional tendency that may correlate with symptoms or barrier stress and could warrant clinical evaluation if issues persist.

What this index can and can't tell you

The most actionable view comes from patterns over time and side-by-side with other biomarkers and your lived experience. When you pair index trends with stool inflammation markers or metabolic labs, you and your clinician can better understand how your gut ecosystem supports digestion, energy, and long-term health, and where it may need support.

Frequently Asked Questions

References

  1. Mo C, Lou X, Xue J, Shi Z, Zhao Y, Wang F, Chen G (2024). The influence of *Akkermansia muciniphila* on intestinal barrier function. *Gut Pathogens*, *16*(1), 41. https://doi.org/10.1186/s13099-024-00635-7
  2. Ma J, Piao X, Mahfuz S, Long S, Wang J (2021). The interaction among gut microbes, the intestinal barrier and short chain fatty acids. *Animal Nutrition*, *9*, 159-174. https://doi.org/10.1016/j.aninu.2021.09.012
  3. Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, Lener E, Mele MC, Gasbarrini A, Collado MC, Cammarota G, Ianiro G (2023). Short-chain fatty-acid-producing bacteria: Key components of the human gut microbiota. *Nutrients*, *15*(9), 2211. https://doi.org/10.3390/nu15092211
  4. Jovel J, Patterson J, Wang W, Hotte N, O'Keefe S, Mitchel T, Perry T, Kao D, Mason AL, Madsen KL, Wong, G. K.-S. (2016). Characterization of the gut microbiome using 16S or shotgun metagenomics. *Frontiers in Microbiology*, *7*, 459. https://doi.org/10.3389/fmicb.2016.00459
  5. Drago L (2025). Navigating microbiome variability: Implications for research, diagnostics, and direct-to-consumer testing. *Frontiers in Microbiology*, *16*, 1580531. https://doi.org/10.3389/fmicb.2025.1580531

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey